Nexalin Technology (NXL) Competitors $1.01 -0.01 (-0.98%) Closing price 04:00 PM EasternExtended Trading$0.98 -0.03 (-2.57%) As of 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NXL vs. HYPR, EDAP, ICCM, MLSS, APT, CTCX, INO, DXR, ECOR, and NEPHShould you be buying Nexalin Technology stock or one of its competitors? The main competitors of Nexalin Technology include Hyperfine (HYPR), Edap Tms (EDAP), IceCure Medical (ICCM), Milestone Scientific (MLSS), Alpha Pro Tech (APT), Carmell (CTCX), Inovio Pharmaceuticals (INO), Daxor (DXR), electroCore (ECOR), and Nephros (NEPH). These companies are all part of the "medical equipment" industry. Nexalin Technology vs. Its Competitors Hyperfine Edap Tms IceCure Medical Milestone Scientific Alpha Pro Tech Carmell Inovio Pharmaceuticals Daxor electroCore Nephros Hyperfine (NASDAQ:HYPR) and Nexalin Technology (NASDAQ:NXL) are both small-cap medical equipment companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, valuation, risk, dividends, analyst recommendations, institutional ownership and media sentiment. Does the media prefer HYPR or NXL? In the previous week, Hyperfine and Hyperfine both had 1 articles in the media. Hyperfine's average media sentiment score of 1.89 equaled Nexalin Technology'saverage media sentiment score. Company Overall Sentiment Hyperfine Very Positive Nexalin Technology Very Positive Is HYPR or NXL more profitable? Hyperfine has a net margin of -343.42% compared to Nexalin Technology's net margin of -6,529.77%. Hyperfine's return on equity of -74.19% beat Nexalin Technology's return on equity.Company Net Margins Return on Equity Return on Assets Hyperfine-343.42% -74.19% -62.40% Nexalin Technology -6,529.77%-277.92%-245.37% Which has higher earnings & valuation, HYPR or NXL? Nexalin Technology has lower revenue, but higher earnings than Hyperfine. Hyperfine is trading at a lower price-to-earnings ratio than Nexalin Technology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHyperfine$12.89M4.83-$40.72M-$0.54-1.48Nexalin Technology$170K102.07-$7.61M-$0.83-1.22 Do analysts prefer HYPR or NXL? Hyperfine presently has a consensus target price of $1.06, suggesting a potential upside of 32.50%. Nexalin Technology has a consensus target price of $5.00, suggesting a potential upside of 395.05%. Given Nexalin Technology's stronger consensus rating and higher probable upside, analysts clearly believe Nexalin Technology is more favorable than Hyperfine.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hyperfine 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Nexalin Technology 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals and insiders hold more shares of HYPR or NXL? 15.0% of Hyperfine shares are held by institutional investors. Comparatively, 0.7% of Nexalin Technology shares are held by institutional investors. 31.0% of Hyperfine shares are held by company insiders. Comparatively, 25.3% of Nexalin Technology shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has more volatility and risk, HYPR or NXL? Hyperfine has a beta of 1.01, meaning that its share price is 1% more volatile than the S&P 500. Comparatively, Nexalin Technology has a beta of 3.7, meaning that its share price is 270% more volatile than the S&P 500. SummaryHyperfine beats Nexalin Technology on 8 of the 14 factors compared between the two stocks. Get Nexalin Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for NXL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NXL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXL vs. The Competition Export to ExcelMetricNexalin TechnologyTechnology Services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$17.52M$2.43B$15.09B$9.32BDividend YieldN/A1.45%2.76%4.05%P/E Ratio-1.2231.0228.1719.68Price / Sales102.0739.3544.46100.28Price / CashN/A43.7226.2457.53Price / Book3.616.086.445.67Net Income-$7.61M$33.22M$196.70M$257.51M7 Day Performance2.02%0.88%0.50%0.52%1 Month Performance-15.13%7.46%5.42%8.84%1 Year Performance-29.37%33.62%21.87%14.18% Nexalin Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXLNexalin Technology2.9828 of 5 stars$1.01-1.0%$5.00+395.0%-28.7%$17.52M$170K-1.223Positive NewsHYPRHyperfine3.1395 of 5 stars$0.77-4.4%$1.06+38.6%-24.1%$62.27M$12.89M-1.42190EDAPEdap Tms3.0461 of 5 stars$1.57-1.3%$8.50+441.4%-70.3%$59.45M$69.18M-2.53230Gap DownICCMIceCure Medical2.3189 of 5 stars$1.05-0.5%$2.50+138.1%+34.7%$58.56M$3.27M-3.7560Gap DownMLSSMilestone Scientific2.9776 of 5 stars$0.68+1.5%$1.25+83.8%-33.3%$52.58M$8.61M-9.7130Negative NewsAPTAlpha Pro Tech1.1433 of 5 stars$4.78+0.6%N/A-18.8%$51.93M$58.18M12.92120CTCXCarmellN/A$2.44+0.8%N/A+58.4%$51.01M$32.84K0.0014Gap UpINOInovio Pharmaceuticals4.0825 of 5 stars$1.33flat$9.75+633.1%-88.2%$48.78M$283.10K-0.42320High Trading VolumeDXRDaxor4.0892 of 5 stars$9.86+0.3%$25.00+153.5%+3.3%$47.55MN/A0.0037ECORelectroCore3.4037 of 5 stars$6.09-0.3%$25.50+318.7%+10.7%$45.34M$25.18M-3.9050NEPHNephros3.0571 of 5 stars$4.08+1.2%$5.00+22.5%+60.5%$42.72M$14.16M58.2930News CoverageHigh Trading Volume Related Companies and Tools Related Companies Hyperfine Alternatives Edap Tms Alternatives IceCure Medical Alternatives Milestone Scientific Alternatives Alpha Pro Tech Alternatives Carmell Alternatives Inovio Pharmaceuticals Alternatives Daxor Alternatives electroCore Alternatives Nephros Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NXL) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | SponsoredNvidia’s next AI move could catch traders flat-footedTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nexalin Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nexalin Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
